Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.48 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.44 |
| ▸ | IAPP | P10997 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27986826 | 0.85 | PTGS1 (0.50) | PTGS1PTGS2HMGB1CXCL12IAPP | |
| SCHEMBL11704984 | 0.84 | GAA (0.55) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3580792 | 0.83 | NPSR1 (0.55) | PTGS1PTGS2HMGB1CXCL12S1PR1 | |
| SCHEMBL5831251 | 0.83 | ALDH1A1 (0.50) | ALDH1A1PTGS1PTGS2HMGB1CXCL12 | |
| SCHEMBL21712571 | 0.82 | NPC1 (0.41) | ALDH1A1PTGS1PTGS2HMGB1CXCL12 | |
| SCHEMBL4972642 | 0.82 | PTGS1 (0.47) | ALDH1A1PTGS1PTGS2HMGB1CXCL12 | |
| SCHEMBL20630754 | 0.82 | ALOX5 (0.47) | ALDH1A1PTGS1PTGS2HMGB1CXCL12 | |
| SCHEMBL4972635 | 0.82 | PTGS1 (0.47) | PTGS1PTGS2HMGB1CXCL12S1PR1 | |
| SCHEMBL15262494 | 0.82 | ALDH1A1 (0.48) | ALDH1A1IAPPCYP1A2CYP3A4MAOA | |
| SCHEMBL9242013 | 0.80 | POLB (0.49) | ALDH1A1PTGS1PTGS2HMGB1CXCL12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479784-B2 | Trisphenol derivative | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20230234905-A1 | NOVEL TRISPHENOL DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| CN-115916734-A | Novel triphenol derivatives | 本州化学工业株式会社 | 2023-04-04 | — | — | CN | disclosed |
| US-8110532-B2 | Antioxidant compositions | CHEMTURA CORPORATION (US) | 2012-02-07 | — | — | US | disclosed |
| US-8007877-B2 | Liquid crystal optical modulation element and optical head device | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-08-30 | — | — | US | disclosed |
| EP-2079747-B1 | HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS | PFIZER LTD (GB) | 2011-03-09 | — | — | EP | disclosed |
| US-20110037910-A1 | LIQUID CRYSTAL OPTICAL MODULATION ELEMENT AND OPTICAL HEAD DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-02-17 | — | — | US | disclosed |
| US-7820250-B2 | Liquid crystal optical modulation element and optical head device | ASAHI GLASS COMPANY, LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20100130396-A1 | ANTIOXIDANT COMPOSITIONS | CHEMTURA CORPORATION (US) | 2010-05-27 | — | — | US | disclosed |
| EP-2079747-A1 | HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS | Pfizer Limited (GB) | 2009-07-22 | — | — | EP | disclosed |
| US-7494960-B2 | Lubricant compositions comprising an antioxidant blend | CROMPTON CORPORATION (US) | 2009-02-24 | — | — | US | disclosed |
| US-20080161288-A1 | COMPOUNDS | PFIZER INC. | 2008-07-03 | — | — | US | disclosed |
| WO-2008044127-A1 | HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS | PFIZER LIMITED (GB) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479784-B2 | Trisphenol derivative | TTPA, CCNA2, CDK2AP2 | ALDH1A1 1566/4885PTGS1 801/4885PTGS2 145/4885 |
| US-20230234905-A1 | NOVEL TRISPHENOL DERIVATIVE | TTPA, CDK2AP2, CDKL2 | ALDH1A1 2038/4885PTGS1 1135/4885PTGS2 271/4885 |
| US-20080161288-A1 | COMPOUNDS | ADRB2, ADRB1, ADRA2C | ALDH1A1 295/4885PTGS1 1214/4885PTGS2 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.